These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Enzymatic kinetic analyses that employ high-performance liquid chromatography. Competition between orotate- and hypoxanthine/guanine-phosphoribosyltransferases for a common substrate. Chung SH; Sloan DL J Chromatogr; 1986 Dec; 371():71-81. PubMed ID: 3549748 [TBL] [Abstract][Full Text] [Related]
4. Orotate phosphoribosyltransferase from yeast: studies of the structure of the pyrimidine substrate binding site. Ashton RW; Strauss RS; Chung SH; Sloan DL Arch Biochem Biophys; 1989 Aug; 272(2):421-32. PubMed ID: 2665650 [TBL] [Abstract][Full Text] [Related]
5. Identification of the active sites of human and schistosomal hypoxanthine-guanine phosphoribosyltransferases by GMP-2',3'-dialdehyde affinity labeling. Kanaani J; Maltby D; Focia P; Wang CC Biochemistry; 1995 Nov; 34(46):14987-96. PubMed ID: 7578112 [TBL] [Abstract][Full Text] [Related]
6. Half-of-sites binding of orotidine 5'-phosphate and alpha-D-5-phosphorylribose 1-diphosphate to orotate phosphoribosyltransferase from Saccharomyces cerevisiae supports a novel variant of the Theorell-Chance mechanism with alternating site catalysis. McClard RW; Holets EA; MacKinnon AL; Witte JF Biochemistry; 2006 Apr; 45(16):5330-42. PubMed ID: 16618122 [TBL] [Abstract][Full Text] [Related]
7. Enzymatic assay procedures that employ high-performance liquid chromatography: competition between phosphoribosyltransferases for a common substrate. Sloan DL; Ali LZ; Aybar-Batista D; Yan C; Hess SL J Chromatogr; 1984 Dec; 316():43-52. PubMed ID: 6241619 [TBL] [Abstract][Full Text] [Related]
12. Differential inhibitory effects of GMP-2',3'-dialdehyde on human and schistosomal hypoxanthine-guanine phosphoribosyltransferases. Kanaaneh J; Craig SP; Wang CC Eur J Biochem; 1994 Jul; 223(2):595-601. PubMed ID: 7519983 [TBL] [Abstract][Full Text] [Related]
13. 31P-NMR study of the orotate phosphoribosyltransferase equilibrium with thiopyrophosphate as substrate. Tavares A; Lee CS; O'Sullivan WJ Biochim Biophys Acta; 1987 Jul; 913(3):279-84. PubMed ID: 3036235 [TBL] [Abstract][Full Text] [Related]
14. The role of divalent magnesium in activating the reaction catalyzed by orotate phosphoribosyltransferase. Bhatia MB; Grubmeyer C Arch Biochem Biophys; 1993 Jun; 303(2):321-5. PubMed ID: 7685580 [TBL] [Abstract][Full Text] [Related]
15. The crystal structure of the orotate phosphoribosyltransferase complexed with orotate and alpha-D-5-phosphoribosyl-1-pyrophosphate. Scapin G; Ozturk DH; Grubmeyer C; Sacchettini JC Biochemistry; 1995 Aug; 34(34):10744-54. PubMed ID: 7545004 [TBL] [Abstract][Full Text] [Related]
16. Kinetic mechanism of human hypoxanthine-guanine phosphoribosyltransferase: rapid phosphoribosyl transfer chemistry. Xu Y; Eads J; Sacchettini JC; Grubmeyer C Biochemistry; 1997 Mar; 36(12):3700-12. PubMed ID: 9132023 [TBL] [Abstract][Full Text] [Related]
18. Studies of the kinetic mechanism of hypoxanthine-guanine phosphoribosyltransferase from yeast. Ali LZ; Sloan DL J Biol Chem; 1982 Feb; 257(3):1149-55. PubMed ID: 7035445 [TBL] [Abstract][Full Text] [Related]
19. Divalent metal ion activation of the yeast orotate phosphoribosyltransferase catalyzed reaction. Victor J; Leo-Mensah A; Sloan DL Biochemistry; 1979 Aug; 18(16):3597-604. PubMed ID: 224912 [No Abstract] [Full Text] [Related]
20. Patterns of phosphoribosylpyrophosphate and ribose-5-phosphate concentration and generation in fibroblasts from patients with gout and purine overproduction. Becker MA J Clin Invest; 1976 Feb; 57(2):308-18. PubMed ID: 176178 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]